銆€銆€
銆€銆€缁忚繃璇勪及锛屼笓瀹跺皬缁勫緱鍑虹粨璁猴紝鍦ㄥ缓璁殑浣跨敤鏉′欢涓嬭娈栧6鑿�(鑿屾牚FCC-3204) 娌逛綔涓烘柊鍨嬮鍝佹槸瀹夊叏鐨勩€傞儴鍒嗗師鏂囨姤閬撳涓嬶細
銆€銆€
銆€銆€Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the safety of an extension of use of oil from Schizochytrium limacinum (strain FCC-3204) as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The extension of use pertains to the use of the NF as a food ingredient in protein products at a maximum use level of 1 g of docosahexaenoic acid (DHA) in 100 g of product. The Panel considers that the information provided on the composition and the production process is sufficiently described and does not raise safety concerns. S. limacinum was attributed the qualified presumption of safety (QPS) status with the qualification ‘for production purposes only’. Data provided demonstrated the absence of viable cells in the NF. Under the proposed extension of use, the highest intake estimate (at the 95th percentile) of DHA from the NF in protein products is 6.3 mg DHA/kg bw per day for adolescents. The Panel notes that the exposure to DHA from the new intended use of the NF in protein products is very low compared to the exposure to DHA from the already authorised food categories (excluding food supplements). The Panel concludes that the NF (oil from S. limacinum (FCC-3204)) is safe under the new intended use.
銆€銆€
銆€銆€鏈枃鐢遍鍝佷紮浼寸綉椋熷搧璧勮涓績缂栬緫锛屼緵缃戝弸鍙傝€冿紝鏈変换浣曠枒闂紝璇疯仈绯籲ews@www.sqrdapp.com銆�